Icad Current Liabilities

ICAD
 Stock
  

USD 1.77  0.05  2.75%   

Icad Inc fundamentals help investors to digest information that contributes to Icad's financial success or failures. It also enables traders to predict the movement of Icad Stock. The fundamental analysis module provides a way to measure Icad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icad stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
As of December 5, 2022, Current Liabilities is expected to decline to about 14.5 M.

Icad Current Liabilities Analysis

Icad's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Icad Current Liabilities

14.47 Million

Current Liabilities 
 = 
Payables 
Accrued Debt 
More About Current Liabilities | All Equity Analysis

Current Icad Current Liabilities

    
  14.28 M  
Most of Icad's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Icad Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Current Liabilities. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.

Icad Current Liabilities Historical Pattern

Today, most investors in Icad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icad's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Icad current liabilities as a starting point in their analysis.
   Icad Current Liabilities   
Share
       Timeline  
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare to competition

Icad Total Liabilities

Total Liabilities

22.1 Million

Icad Total Liabilities is projected to decrease significantly based on the last few years of reporting. The past year's Total Liabilities was at 15.67 Million
In accordance with the recently published financial statements, Icad Inc has a Current Liabilities of 14.28 M. This is 99.19% lower than that of the Health Care Technology sector and 97.98% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.82% higher than that of the company.

Icad Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.
Icad is currently under evaluation in current liabilities category among related companies.

Icad Current Valuation Drivers

We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(119.8 K)(92.96 K)(98.2 K)(154.05 K)(82.08 K)(88.56 K)
Revenue Per Employee236.15 K264.13 K227.1 K259.8 K245.53 K282.52 K
Average Assets35.47 M29.1 M39.29 M47.28 M67.5 M58.43 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(13.17 M)(8.26 M)(12.9 M)(16.98 M)(10.79 M)(11.64 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(12.66 M)(7.76 M)(12.05 M)(16.52 M)(10.55 M)(11.38 M)
Earnings before Tax(14.27 M)(8.97 M)(13.51 M)(17.57 M)(11.24 M)(12.13 M)
Average Equity20.56 M9.72 M7.18 M24.36 M50.18 M39.66 M
Enterprise Value51.51 M61.34 M153.32 M290.71 M146.27 M137.29 M
Free Cash Flow(7.73 M)(4.17 M)(7.4 M)(7.45 M)(9.97 M)(10.23 M)
Invested Capital6.36 M9.5 M20.54 M11.15 M4.79 M6.34 M
Invested Capital Average3.29 M5.82 M16.51 M10.77 M8.11 M8.2 M
Market Capitalization56.8 M62.06 M150.42 M303.51 M180.79 M160.4 M
Tangible Asset Value21.84 M21.82 M32.2 M46.33 M53.15 M45.72 M
Working Capital9.14 M7.97 M10.36 M25.55 M35.34 M38.13 M

Icad Fundamentals

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Current Liabilities15 M14.5 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Icad Piotroski F Score and Icad Altman Z Score analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
46.3 M
Quarterly Revenue Growth YOY
(0.32) 
Return On Assets
(0.15) 
Return On Equity
(0.34) 
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.